Fig. 2.
Kaplan-Meier analyses determining the role of pathological complete response in the breast (2A & 2B) and axilla (2C & 2D) as a surrogate biomarker of survival in patients treated with neoadjuvant therapies.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.